Article
The Application of Nanobody in CAR-T Therapy
8 Feb 2021
Abstract excerpt
Chimeric antigen receptor (CAR) T therapy represents a form of immune cellular therapy with clinical efficacy and a specific target. A typical chimeric antigen receptor (CAR) construct consists of an antigen binding domain, a transmembrane domain, and a cytoplasmic domain. Nanobodies have been widely applied as the antigen binding domain of CAR-T due to their small size, optimal stability, high affinity, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
